Presented by the ISCT ANZ Regional Executive Committee

November 23, 2023

Webinar Description:

AusBiotech and Medicines Australia have partnered to co-lead a new Cell and Gene Catalyst initiative. This national joint venture is a collaborative effort between the two peak industry bodies. The Catalyst aims to accelerate the development and commercialisation of cell and gene therapies in Australia and strengthen Australian capabilities across the entire value chain. 

In this webinar, Dr Marguerite Evans-Galea AM will outline Catalyst’s role in establishing an end-to-end value chain for discovering, developing, manufacturing and distributing world-class cell and gene therapies while promoting job creation and commercialising research in Australia. Dr Evans-Galea will provide an overview of the National Cell and Gene Manufacturing Blueprint recently published by Ausbiotech and discuss approaches to expand manufacturing capabilities and capacity in Australia.

Key Learning Objectives: 

• Attract, build, and retain world-class talent to support skillset and workforce requirements
• Foster collaboration and knowledge sharing across the industry to accelerate the pace of innovation
• Create a clear regulatory and market access pathway that is aligned with global markets, ensuring that new therapies can reach patients
• Build Australian capability from research and development to manufacturing, clinical trials and successful commercialization.